These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 2449616)

  • 61. Buprenorphine/naloxone: a review of its use in the treatment of opioid dependence.
    Orman JS; Keating GM
    Drugs; 2009; 69(5):577-607. PubMed ID: 19368419
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Self-administration of intravenous buprenorphine and the buprenorphine/naloxone combination by recently detoxified heroin abusers.
    Comer SD; Collins ED
    J Pharmacol Exp Ther; 2002 Nov; 303(2):695-703. PubMed ID: 12388653
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Buprenorphine and naloxone alone and in combination in opioid-dependent humans.
    Preston KL; Bigelow GE; Liebson IA
    Psychopharmacology (Berl); 1988; 94(4):484-90. PubMed ID: 2453895
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Intravenous hydromorphone: effects in opiate-free and methadone maintenance subjects.
    McCaul ME; Stitzer ML; Bigelow GE; Liebson IA
    NIDA Res Monogr; 1983 Apr; 43():238-44. PubMed ID: 6192340
    [No Abstract]   [Full Text] [Related]  

  • 65. Butorphanol-precipitated withdrawal in opioid-dependent human volunteers.
    Preston KL; Bigelow GE; Liebson IA
    NIDA Res Monogr; 1987; 76():157-61. PubMed ID: 2449617
    [No Abstract]   [Full Text] [Related]  

  • 66. Acute effects of buprenorphine, hydromorphone and naloxone in methadone-maintained volunteers.
    Strain EC; Preston KL; Liebson IA; Bigelow GE
    J Pharmacol Exp Ther; 1992 Jun; 261(3):985-93. PubMed ID: 1376362
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The implementation of buprenorphine/naloxone in college health practice.
    DeMaria PA; Patkar AA
    J Am Coll Health; 2008; 56(4):391-3. PubMed ID: 18316282
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Abuse liability assessment of buprenorphine-naloxone combinations.
    Bigelow GE; Preston KL; Liebson IA
    NIDA Res Monogr; 1987; 76():145-9. PubMed ID: 2449616
    [No Abstract]   [Full Text] [Related]  

  • 69.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 70.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 71.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 72.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 73.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 74.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 4.